Burns ML - Search Results

1

Inotropic Therapy in Newborns, A Population-Based National Registry Study.

Burns ML, Stensvold HJ, Risnes K, Guthe HJ, Astrup H, Nordhov SM, Selberg TR, Rønnestad A, Lang AM; Norwegian Neonatal Network. Burns ML, et al. Pediatr Crit Care Med. 2016 Oct;17(10):948-956. doi: 10.1097/PCC.0000000000000898. Pediatr Crit Care Med. 2016. PMID: 27500723

2

The authors reply.

Burns ML, Lang AM. Burns ML, et al. Pediatr Crit Care Med. 2017 Jan;18(1):98. doi: 10.1097/PCC.0000000000001023. Pediatr Crit Care Med. 2017. PMID: 28060165 No abstract available.

3

Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability.

Svendsen T, Brodtkorb E, Baftiu A, Burns ML, Johannessen SI, Johannessen Landmark C. Svendsen T, et al. Among authors: burns ml. Neurochem Res. 2017 Jul;42(7):2077-2083. doi: 10.1007/s11064-017-2234-8. Epub 2017 Mar 27. Neurochem Res. 2017. PMID: 28349359

4

Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines.

Reimers A, Berg JA, Burns ML, Brodtkorb E, Johannessen SI, Johannessen Landmark C. Reimers A, et al. Among authors: burns ml. Drug Des Devel Ther. 2018 Feb 8;12:271-280. doi: 10.2147/DDDT.S154388. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29467570 Free PMC article.

5

The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice.

Johannessen Landmark C, Svendsen T, Dinarevic J, Kufaas RF, Reimers A, Brodtkorb E, Baftiu A, Burns ML, Johannessen SI. Johannessen Landmark C, et al. Among authors: burns ml. Ther Drug Monit. 2016 Aug;38(4):499-505. doi: 10.1097/FTD.0000000000000306. Ther Drug Monit. 2016. PMID: 27414974

6

Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway, 2004-2015.

Baftiu A, Feet SA, Larsson PG, Burns ML, Henning O, Sætre E, Molden E, Granas AG, Johannessen SI, Landmark CJ. Baftiu A, et al. Among authors: burns ml. Epilepsy Res. 2018 Jan;139:35-42. doi: 10.1016/j.eplepsyres.2017.11.001. Epub 2017 Nov 11. Epilepsy Res. 2018. PMID: 29175562

7

Therapeutic Drug Monitoring of Clobazam and Its Metabolite-Impact of Age and Comedication on Pharmacokinetic Variability.

Burns ML, Baftiu A, Opdal MS, Johannessen SI, Landmark CJ. Burns ML, et al. Ther Drug Monit. 2016 Jun;38(3):350-7. doi: 10.1097/FTD.0000000000000272. Ther Drug Monit. 2016. PMID: 26751267

8

Pharmacokinetic variability of valproate in women of childbearing age.

Johannessen Landmark C, Burns ML, Baftiu A, Farmen AH, Lossius MI, Johannessen SI, Tomson T. Johannessen Landmark C, et al. Among authors: burns ml. Epilepsia. 2017 Oct;58(10):e142-e146. doi: 10.1111/epi.13872. Epub 2017 Aug 22. Epilepsia. 2017. PMID: 28833045

9

Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice.

Johannessen Landmark C, Beiske G, Baftiu A, Burns ML, Johannessen SI. Johannessen Landmark C, et al. Among authors: burns ml. Seizure. 2015 May;28:88-91. doi: 10.1016/j.seizure.2015.02.017. Epub 2015 Feb 21. Seizure. 2015. PMID: 25758302 Free article.

10

Efficacy, tolerability and pharmacokinetic variability of brivaracetam in adults with difficult-to-treat epilepsy.

Svendsen T, Brodtkorb E, Linge HL, Burns ML, Johannessen SI, Nakken KO, Lossius MI, Landmark CJ. Svendsen T, et al. Among authors: burns ml. Epilepsy Res. 2022 Jul;183:106946. doi: 10.1016/j.eplepsyres.2022.106946. Epub 2022 May 20. Epilepsy Res. 2022. PMID: 35609355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page